Who we are?
Arista is a privately held, joint venture company formed by Limagrain, a fifty-year-old farmer-founded and directed, world player in wheat seeds, and CSIRO, a globally recognized organization focused on using science to make a positive difference in the world for nearly one hundred years.
These 2 companies began collaborating on fundamental research in wheat starch 20 years ago, and joined their efforts and expertise in 2006 to create Arista, and develop a wheat with direct consumer health benefits.
Arista High Fiber Wheat contains elevated levels of amylose, a starch molecule which occurs naturally in wheat and is resistant to digestion in small intestine. But once in the large bowel, it will feed the microbiome, thereby acting as a prebiotic, with a significant positive impact on digestive health.
latest News
Glycemic response study
June 2019, Adelaide, Australia. High-amylose wheat lowers the postprandial glycemic response to bread in healthy adults. Replacing…
Read more
New trial against Arista dismissed
January 2019, Sydney, Australia. Arista announces that the lawsuit initiated by Arcadia Biosciences has been dismissed. This…
Read more
Resistant Starch in Wheat foods products
September 2018, CSIRO, Australia and Limagrain, France. Enhancing the nutritional quality of staple foods such as cereals…
Read more
Patent dispute on High Fiber Wheat
September 2018, Sydney, Australia Arista is pleased to announce that it has successfully defended a patent in…
Read more
Latest Posts
-
Glycemic response study
June 2019, Adelaide, Australia. High-amylose wheat lowers…
-
New trial against Arista dismissed
January 2019, Sydney, Australia. Arista announces that…